Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Providing Comprehensive Harm Reduction Via Telemedicine for PWID Using Syringe Services Programs: a Feasibility Study

NCT04521920 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT04521920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04521920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Providing Comprehensive Harm Reduction Via Telemedicine for PWID Using Syringe Services Programs: a Feasibility Study
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Completed
Start date
November 9, 2020
Completion date
August 30, 2021
Enrollment
17 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, opioid use, opioid-use disorder, risk reduction